UnknownNot Applicable

Mini- Percutaneous Nephrolithotomy Versus Standard Percutaneous Nephrolithotomy in the Treatment of Renal Stones.

Egypt210 participantsStarted 2019-05-01

Plain-language summary

The EUA Urolithiasis Guidelines Panel meta-analysis suggest that mPNL is at least as efficacious and safe as sPNL for the removal of renal calculi. However, the quality of the evidence was poor, drawn mainly from small studies, the majority of which were single-arm case series, and only one of which was RCT. The risks of bias and confounding were high, highlighting the need for more reliable data from RCTs. So, the Panel recommended for more clinical research . The aim of this study is to compare between PNL and mPNL through a randomized controlled trial.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient 18 years or older.
✓. ASA I or II
✓. Renal stones ≥ 2 cm
✓. Lower calyceal stone ≥ 1 cm
✓. Failure of other modalities of treatment as ESWL and RIRS.

Exclusion criteria

✕. S.creatinine \> 2mg/dl.
✕. Patients with active UTI.
✕. Patients on anticoagulant.
✕. Age \<18 years.
✕. Ureteral obstruction preventing the insertion of a ureteral stent.

What they're measuring

Assessment of stone free rate (SFR)

Timeframe: 2 years

Trial details

NCT IDNCT04153461

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-01

View on ClinicalTrials.gov More Urolithiasis trials